Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/d8/23/c0/d823c0cf-437c-210a-b04e-bfef99d23241/mza_2106615490319385882.jpg/600x600bb.jpg
ASX BRIEFS
Andrew Musgrave
179 episodes
3 days ago
Send us a text A quieter revolution is unfolding inside battery recycling: selective chemistry that finally makes economic and environmental sense. We sit down with Dr Ebbe Dommisse, CEO of Iondrive, to explore how deep eutectic solvents enable clean, closed-loop recovery of critical minerals from battery black mass, e-waste, magnets, and end-of-life solar panels—and why that unlocks real scale. We trace the strategic entry into Europe through a €3.1 million German battery recycling consorti...
Show more...
Investing
Business
RSS
All content for ASX BRIEFS is the property of Andrew Musgrave and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text A quieter revolution is unfolding inside battery recycling: selective chemistry that finally makes economic and environmental sense. We sit down with Dr Ebbe Dommisse, CEO of Iondrive, to explore how deep eutectic solvents enable clean, closed-loop recovery of critical minerals from battery black mass, e-waste, magnets, and end-of-life solar panels—and why that unlocks real scale. We trace the strategic entry into Europe through a €3.1 million German battery recycling consorti...
Show more...
Investing
Business
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/d8/23/c0/d823c0cf-437c-210a-b04e-bfef99d23241/mza_2106615490319385882.jpg/600x600bb.jpg
AROVELLA THERAPEUTICS LTD (ALA) - Killer Cells on a Mission: The iNKT Cell Cancer Therapy Story
ASX BRIEFS
16 minutes
2 months ago
AROVELLA THERAPEUTICS LTD (ALA) - Killer Cells on a Mission: The iNKT Cell Cancer Therapy Story
Send us a text Revolutionary cancer therapies are no longer confined to science fiction. Dr. Michael Baker, CEO of Arovella Therapeutics (ASX: ALA), reveals how the company's groundbreaking work with invariant natural killer T-cells (iNKT cells) is transforming cancer treatment through truly off-the-shelf cell therapies. Traditional cell therapies face significant hurdles – they're expensive, time-consuming to produce, and limited to treating the same patient they're derived from. Arovella's...
ASX BRIEFS
Send us a text A quieter revolution is unfolding inside battery recycling: selective chemistry that finally makes economic and environmental sense. We sit down with Dr Ebbe Dommisse, CEO of Iondrive, to explore how deep eutectic solvents enable clean, closed-loop recovery of critical minerals from battery black mass, e-waste, magnets, and end-of-life solar panels—and why that unlocks real scale. We trace the strategic entry into Europe through a €3.1 million German battery recycling consorti...